Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.
DUBLIN--(BUSINESS WIRE)--The "Global Transdermal Patches Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global transdermal patches market is ...
The transdermal patches market is further segmented based on the patch type, adhesive type, application, distribution channel, end-user, and region. The Drug-In-Adhesives segment is expected to ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global transdermal skin patches market is projected to grow from USD 9.4 billion in 2025 to USD 15.6 billion by 2035, representing a compound annual growth ...
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug ...
Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback